Lundbeck
HLUN-B.CO
#2496
Rank
ยฃ4.59 B
Marketcap
ยฃ4.80
Share price
2.83%
Change (1 day)
22.02%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): ยฃ0.29

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is ยฃ0.28. In 2022 the company made an earnings per share (EPS) of ยฃ0.22 a decrease over its 2021 EPS that were of ยฃ0.49.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.2935.48%
2022ยฃ0.22-55.47%
2021ยฃ0.49-51.83%
2020ยฃ1.01-28.01%
2019ยฃ1.40-44.08%
2018ยฃ2.5151.94%
2017ยฃ1.65126.64%
2016ยฃ0.73-120.84%
2015-ยฃ3.495622.18%
2014-ยฃ0.06103-110.03%
2013ยฃ0.61-28.08%
2012ยฃ0.85-52.1%
2011ยฃ1.77-1.31%
2010ยฃ1.7915.61%
2009ยฃ1.55